Compounds > nitroaspirin
Page last updated: 2024-09-03

nitroaspirin and salicylates

nitroaspirin has been researched along with salicylates in 3 studies

Compound Research Comparison

Studies
(nitroaspirin)		Trials
(nitroaspirin)		Recent Studies (post-2010)
(nitroaspirin)		Studies
(salicylates)		Trials
(salicylates)		Recent Studies (post-2010) (salicylates)
1279813,3178531,678

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Antonelli, E; Del Soldato, P; Federici, B; Fiorucci, S; Mannucci, R; Miglietti, M; Morelli, A; Morelli, O; Santucci, L1
Kato, S; Komoike, Y; Suzuki, K; Takeuchi, K; Ukawa, H1
Amadori, D; Bolla, M; Brigliadori, G; Fabbri, F; Rosetti, M; Tesei, A; Ulivi, P; Vannini, I; Zoli, W1

Other Studies

3 other study(ies) available for nitroaspirin and salicylates

ArticleYear
Gastrointestinal safety of nitric oxide-derived aspirin is related to inhibition of ICE-like cysteine proteases in rats.
    Gastroenterology, 1999, Volume: 116, Issue:5

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Caspase Inhibitors; Caspases; Cyclic GMP; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Gastric Mucosa; Humans; In Situ Nick-End Labeling; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Rats; Salicylates; Time Factors; Tumor Necrosis Factor-alpha; U937 Cells

1999
Low gastric toxicity of nitric oxide-releasing aspirin, NCX-4016, in rats with cirrhosis and arthritis.
    Digestive diseases and sciences, 2001, Volume: 46, Issue:8

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Aspirin; Blood Flow Velocity; Gastric Acid; Gastric Mucosa; Hydrochloric Acid; Liver Cirrhosis; Male; Membrane Potentials; Nitric Oxide Donors; Nitro Compounds; Rats; Rats, Sprague-Dawley; Salicylates; Stomach Ulcer

2001
Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines.
    Apoptosis : an international journal on programmed cell death, 2006, Volume: 11, Issue:8

    Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Caspase 9; Cell Cycle; Cell Line, Tumor; Cytotoxins; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Nitric Oxide Donors; Nitro Compounds; Pancreatic Neoplasms; S-Nitroso-N-Acetylpenicillamine; Salicylates

2006